Replies to post #24998 on Amarantus Bioscience Holdings Inc (AMBS)

[iamnottheone]

I know this is a stretch, but then maybe not.

Consider this,

And he's presenting on the potential for commercial opportunities of MANF at a conference in January. For doubters: Do you really think they're going to present bad data in front of a conference of VC and angel investors and big pharma companies that are paying $400 to attend?

big pharma companies attending conference, they are presented with strong positive results, they digest the results and come up with a buy out offer. AMBS could well see $$$$ at that point. IMO